BCR C.r. Bard Inc.
- 18.95 P/E
- 2.90 P/S
- 4.53 P/B
- 5.646 EPS
- 27.20% Cash ROIC
- 0.66 Cash Ratio
- 0.80 / 0.75 % Dividend
- 643,234.00 Avg. Vol.
- 80.48M Shares
- 8.588B Market Cap.
C. R. Bard, Inc., together with its subsidiaries, engages in the design, manufacture, packaging, distribution, and sale of medical, surgical, diagnostic, and patient care devices worldwide. It offers vascular, urology, oncology, and surgical specialty products. The company's vascular products include percutaneous transluminal angioplasty catheters, guidewires, introducers, and accessories; periphe...
SBWire (press release) - 12 hours ago
The Wall Street Transcript - May 16, 2013
eNews Park Forest - May 13, 2013
Medical Device Company C.R. Bard Pays $48.2 Million to Settle Whistleblower ... - PR Newswire (press release)
ModernHealthcare.com - May 14, 2013
NASDAQ - Apr 24, 2013
4-traders (press release) - May 3, 2013
Forbes - Apr 25, 2013
4-traders (press release) - Apr 23, 2013
Thomson Reuters News & Insight - May 16, 2013
Zacks.com - Apr 22, 2013